Inhibition of AXL signaling in anti-metastatic therapy
Details for Australian Patent Application No. 2011207381 (hide)
International Classifications
Event Publications
26 July 2012 PCT application entered the National Phase
PCT publication WO2011/091305 Priority application(s): WO2011/091305
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2011207387-Excision of transgenes in genetically modified organisms
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser